tradingkey.logo

UK's MHRA Approves Nogapendekin Alfa Inbakicept To Treat Patients With A Type Of Bladder Cancer

ReutersJul 4, 2025 10:10 AM

- UK's MHRA:

  • UK'S MHRA: APPROVES NOGAPENDEKIN ALFA INBAKICEPT TO TREAT ADULT PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER - WEBSITE

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI